Skip to main content

Can any stem-cell paper be trusted?

So, just how untrustworthy is the stem-cell literature? Very, according to one of the field's leading lights, David Shaywitz of the Harvard Stem Cell Institute. He's the author of linkurl:an op-ed piece;https://www.washingtonpost.com/wp-dyn/content/article/2006/01/11/AR2006011102040.html that was meant to defend the beleaguered field of stem-cell research, despite linkurl:fraudulent papers;https://www.the-scientist.com/blog/browse/blogger/13/date/2006-01/ from the lab of Korean researcher Hwang

Written byTabitha M. Powledge
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
So, just how untrustworthy is the stem-cell literature? Very, according to one of the field's leading lights, David Shaywitz of the Harvard Stem Cell Institute. He's the author of linkurl:an op-ed piece;https://www.washingtonpost.com/wp-dyn/content/article/2006/01/11/AR2006011102040.html that was meant to defend the beleaguered field of stem-cell research, despite linkurl:fraudulent papers;https://www.the-scientist.com/blog/browse/blogger/13/date/2006-01/ from the lab of Korean researcher Hwang Woo Suk. But in what was almost an aside, Shaywitz dropped a bombshell:**While most in the field of stem cell research were shocked by the reports of fraud, the shock was only one of degree; it is common knowledge that the bar for publication in this field often has appeared remarkably low, with even well-respected research journals seeming to fall over one another for the privilege of publishing the next hot paper. The result of this frenzy has been an entire body of literature that is viewed with extreme skepticism by most serious stem cell investigators.**It was a bombshell to me, anyway. There is plenty of gossip among science journalists about how the top journals--you know who you are--engage in savage battles to be first with the latest in a handful of hot research fields. And that they define **hot** to mean papers that will grab headlines on TV news and in the New York Times. The Scientist's Ivan Oransky brought this topic up in linkurl:his blog;https://www.the-scientist.com/blog/display/22934/ Tuesday. Scientists grumble too, only not usually for quotation. But this is the first time I've seen a prominent researcher declaring that this unseemly competition has cast doubt--not just on an individual paper or two, but on an entire literature.What is to be done? Must stem-cell researchers conduct their own lab peer review, replicating every bit of each others' work before they try to build on it? Are there structural changes at journals that will help ensure that papers are reporting accurately? The editor of Science, linkurl:Donald Kennedy, says;https://www.sciencemag.org/sciext/hwang2005/kennedy_20060110_transcript.pdf his journal (which published the two fraudulent Hwang papers, now retracted) is considering adding some measures such as improved image analysis. But overall, he doesn't sound optimistic that procedural safeguards will make much difference.Kennedy goes on to argue that such cases are rare. But that's just the point. If we are to believe Shaywitz, in stem-cell research at least, they are not rare at all.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays